173 related articles for article (PubMed ID: 24700270)
1. Influence of surface chemistry on cytotoxicity and cellular uptake of nanocapsules in breast cancer and phagocytic cells.
Youm I; Bazzil JD; Otto JW; Caruso AN; Murowchick JB; Youan BB
AAPS J; 2014 May; 16(3):550-67. PubMed ID: 24700270
[TBL] [Abstract][Full Text] [Related]
2. Uptake and cytotoxicity of docetaxel-loaded hyaluronic acid-grafted oily core nanocapsules in MDA-MB 231 cancer cells.
Youm I; Agrahari V; Murowchick JB; Youan BB
Pharm Res; 2014 Sep; 31(9):2439-52. PubMed ID: 24643931
[TBL] [Abstract][Full Text] [Related]
3. Development of docetaxel nanocapsules for improving in vitro cytotoxicity and cellular uptake in MCF-7 cells.
Singh SK; Banala VT; Gupta GK; Verma A; Shukla R; Pawar VK; Tripathi P; Mishra PR
Drug Dev Ind Pharm; 2015; 41(11):1759-68. PubMed ID: 25686725
[TBL] [Abstract][Full Text] [Related]
4. Encapsulation of docetaxel in oily core polyester nanocapsules intended for breast cancer therapy.
Youm I; Yang XY; Murowchick JB; Youan BB
Nanoscale Res Lett; 2011 Dec; 6(1):630. PubMed ID: 22168815
[TBL] [Abstract][Full Text] [Related]
5. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
Liu Y; Pan J; Feng SS
Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049
[TBL] [Abstract][Full Text] [Related]
6. Entrapment and release kinetics of furosemide from pegylated nanocarriers.
Youm I; Murowchick JB; Youan BB
Colloids Surf B Biointerfaces; 2012 Jun; 94():133-42. PubMed ID: 22386795
[TBL] [Abstract][Full Text] [Related]
7. Oral delivery system prolongs blood circulation of docetaxel nanocapsules via lymphatic absorption.
Attili-Qadri S; Karra N; Nemirovski A; Schwob O; Talmon Y; Nassar T; Benita S
Proc Natl Acad Sci U S A; 2013 Oct; 110(43):17498-503. PubMed ID: 24101508
[TBL] [Abstract][Full Text] [Related]
8. Development of docetaxel nanocrystals surface modified with transferrin for tumor targeting.
Choi JS; Park JS
Drug Des Devel Ther; 2017; 11():17-26. PubMed ID: 28031702
[TBL] [Abstract][Full Text] [Related]
9. Development and evaluation of targeting ligands surface modified paclitaxel nanocrystals.
Sohn JS; Yoon DS; Sohn JY; Park JS; Choi JS
Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():228-237. PubMed ID: 28024581
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of cellular uptake and cytotoxicity of paclitaxel loaded lipid nanocapsules in breast cancer cells.
Valsalakumari R; Yadava SK; Szwed M; Pandya AD; Mælandsmo GM; Torgersen ML; Iversen TG; Skotland T; Sandvig K; Giri J
Int J Pharm; 2021 Mar; 597():120217. PubMed ID: 33486035
[TBL] [Abstract][Full Text] [Related]
11. Optimal structural design of mannosylated nanocarriers for macrophage targeting.
Chen P; Zhang X; Jia L; Prud'homme RK; Szekely Z; Sinko PJ
J Control Release; 2014 Nov; 194():341-9. PubMed ID: 25220160
[TBL] [Abstract][Full Text] [Related]
12. Poly-L-asparagine nanocapsules as anticancer drug delivery vehicles.
Rivera-Rodríguez GR; Alonso MJ; Torres D
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):481-7. PubMed ID: 23954509
[TBL] [Abstract][Full Text] [Related]
13. Long circulating poly(ethylene glycol)-decorated lipid nanocapsules deliver docetaxel to solid tumors.
Khalid MN; Simard P; Hoarau D; Dragomir A; Leroux JC
Pharm Res; 2006 Apr; 23(4):752-8. PubMed ID: 16550475
[TBL] [Abstract][Full Text] [Related]
14. Peptide conjugated polymeric nanoparticles as a carrier for targeted delivery of docetaxel.
Kulhari H; Pooja D; Shrivastava S; V G M N; Sistla R
Colloids Surf B Biointerfaces; 2014 May; 117():166-73. PubMed ID: 24632389
[TBL] [Abstract][Full Text] [Related]
15. Novel drug delivery system based on docetaxel-loaded nanocapsules as a therapeutic strategy against breast cancer cells.
Sánchez-Moreno P; Boulaiz H; Ortega-Vinuesa JL; Peula-García JM; Aránega A
Int J Mol Sci; 2012; 13(4):4906-4919. PubMed ID: 22606019
[TBL] [Abstract][Full Text] [Related]
16. Feasibility of obtaining in situ nanocapsules through modified self-microemulsifying drug delivery systems. A new manufacturing approach for oral route administration.
Llera-Rojas VG; Del Real L A; Mendoza-Muñoz N; Melgoza-Contreras LM; Quintanar-Guerrero D
Drug Dev Ind Pharm; 2017 Jun; 43(6):925-931. PubMed ID: 28105857
[TBL] [Abstract][Full Text] [Related]
17. Preparation of HIFU-triggered tumor-targeted hyaluronic acid micelles for controlled drug release and enhanced cellular uptake.
Zheng S; Jin Z; Han J; Cho S; Nguyen VD; Ko SY; Park JO; Park S
Colloids Surf B Biointerfaces; 2016 Jul; 143():27-36. PubMed ID: 26998864
[TBL] [Abstract][Full Text] [Related]
18. A novel lipid-based nanomicelle of docetaxel: evaluation of antitumor activity and biodistribution.
Ma M; Hao Y; Liu N; Yin Z; Wang L; Liang X; Zhang X
Int J Nanomedicine; 2012; 7():3389-98. PubMed ID: 22848167
[TBL] [Abstract][Full Text] [Related]
19. Perspectives of nanoemulsion assisted oral delivery of docetaxel for improved chemotherapy of cancer.
Verma P; Meher JG; Asthana S; Pawar VK; Chaurasia M; Chourasia MK
Drug Deliv; 2016; 23(2):479-88. PubMed ID: 24901205
[TBL] [Abstract][Full Text] [Related]
20. Co-delivery of docetaxel and palmitoyl ascorbate by liposome for enhanced synergistic antitumor efficacy.
Li J; Guo C; Feng F; Fan A; Dai Y; Li N; Zhao D; Chen X; Lu Y
Sci Rep; 2016 Dec; 6():38787. PubMed ID: 27934917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
